Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects measured by cardiopulmonary exercise testing

Respiration

Volumn 86, Issue 5, 2013, Pages 407-413

  Armstrong, Hilary F ^a,c   Thirapatarapong, Wilawan ^a,b   Dussault, Nicole E ^a   Bartels, Matthew N ^a  

^a Department of Medicine   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NONE   (United States)

Author keywords

Cardiopulmonary exercise test; Interstitial lung disease; Lung transplantation; Pulmonary hypertension; Ventilation perfusion defects

Indexed keywords

ADULT; ARTICLE; BICYCLE ERGOMETER; CARBON DIOXIDE TENSION; CARDIOPULMONARY EXERCISE TEST; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; END TIDAL CARBON DIOXIDE TENSION; FEMALE; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HUMAN; IMAGING SOFTWARE; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; LUNG HEMODYNAMICS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ALLERGIC PNEUMONITIS; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPH; ELECTROCARDIOGRAPHY; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART INDEX; HEART OUTPUT; LUNG ARTERY PRESSURE; LUNG GAS EXCHANGE; LUNG MINUTE VOLUME; LUNG PERFUSION; LUNG SARCOIDOSIS; LUNG VENTILATION; MEDICAL RECORD REVIEW; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PH; RESIDUAL VOLUME; RETROSPECTIVE STUDY; TELEMETRY; TIDAL VOLUME; TOTAL LUNG CAPACITY; VOLUME PLETHYSMOGRAPH;

CARBON DIOXIDE; OXYGEN;

AGED; BREATH TESTS; CARBON DIOXIDE; DIAGNOSIS, DIFFERENTIAL; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY CIRCULATION; PULMONARY VENTILATION; RETROSPECTIVE STUDIES;

EID: 84898597691     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000350445     Document Type: Article

References (23)

1. Strange C, Highland KB: Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2005; 11: 452-455. (Pubitemid 41291091)
2. Polomis D, Runo JR, Meyer KC: Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2008; 14: 462-469.
3. Hansen JE, Ulubay G, Chow BF, Sun XG, Wasserman K: Mixed-expired and end-tidal CO 2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases. Chest 2007; 132: 977-983.
4. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-277.
5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
6. Group NETT: A randomized trial comparing lung volume reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-2073.
7. American Thoracic Society, American College of Chest Physicians: ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Car Med 2003; 167: 211-277.
8. Wasserman K, Hansen J, Sue D, Stringer W, Whipp B: Principles of Exercise Testing and Interpretation, ed 3. Philadelphia, Lippincott Williams & Wilkins, 1999.
9. Jones N, Makrides L, Hitchcock C, Chypchar T, McCartney N: Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131: 700-708. (Pubitemid 15066853)
10. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson D, Mac- Intyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522. (Pubitemid 41264217)
11. Crapo R, Morris A, Clayton P, Nixon C: Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982; 18: 419-425. (Pubitemid 12117075)
12. Crapo R, Morris A, Gardner R: Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-664. (Pubitemid 11117589)
13. Crapo R, Morris A: Standardized singlebreath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123: 185-189. (Pubitemid 11146393)
14. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practice Guidelines (CPG): Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493- 2537.
15. Badesch DB, Champion HC, Gomez Sanchez MA, Hoeper MM, Loyd JE, Manes A, Mc- Goon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A: Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S55-S66.
16. Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, Kontou PK, Chavouzis N, Nakou C, Argyropoulou P, Wasserman K, Stanopoulos I: Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology 2011; 16: 451-458.
17. Launay D, Mouthon L, Hachulla E, Pagnoux C, de Groote P, Remy-Jardin M, Matran R, Lambert M, Queyrel V, Morell-Dubois S, Guillevin L, Hatron P-Y: Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 2007; 34: 1005-1011. (Pubitemid 46774846)
18. Pitsiou G, Papakosta D, Bouros D: Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration 2011; 82: 294-304.
19. Andersen CU, Mellemkjær S, Hilberg O, Nielsen-Kudsk JE, Simonsen U, Bendstrup E: Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test. Respir Med 2012; 106: 875-882.
20. Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J: Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2004; 170: 360-365. (Pubitemid 39214607)
21. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF: Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
22. Dumitrescu D, Oudiz RJ, Karpouzas G, Hovanesyan A, Jayasinghe A, Hansen JE, Rosenkranz S, Wasserman K: Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS One 2010; 5:e14293.
23. Arena R, Guazzi M, Myers J, Grinnen D, Forman DE, Lavie CJ: Cardiopulmonary exercise testing in the assessment of pulmonary hypertension. Expert Rev Respir Med 2011; 5: 281- 293.